Ultralife (ULBI) Equity Average (2011 - 2026)

Ultralife has reported Equity Average for 16 years, with the latest figure at $129.9 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 4.07% year-over-year to $129.9 million; the trailing twelve-month figure through Mar 2026 stood at $129.9 million (down 4.07% YoY), and the FY2025 full-year result was $132.2 million, up 1.81% from the prior year.
• Equity Average for Q1 2026 stood at $129.9 million, down from $133.8 million in the prior quarter.
• The five-year high for Equity Average was $138.0 million in Q3 2025, with the low at $115.8 million in Q4 2022.
• Average Equity Average over 5 years is $126.3 million, with a median of $127.2 million recorded in 2024.
• Year-over-year, Equity Average grew 11.1% in 2024 and decreased 4.07% in 2026.
• Tracing ULBI's Equity Average over 5 years: stood at $115.8 million in 2022, then advanced by 6.68% to $123.5 million in 2023, then gained by 8.8% to $134.4 million in 2024, then decreased by 0.46% to $133.8 million in 2025, then dropped by 2.92% to $129.9 million in 2026.
• The last three Equity Average figures came in at $129.9 million (Q1 2026), $133.8 million (Q4 2025), and $138.0 million (Q3 2025), per Business Quant data.

Peer Comparison